Published • loading... • Updated
Manufacturer of Ozempic Loses Liminar Against Brazilian Pharmacist
Summary by Metrópoles
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
TRF-2 maintained the registration of the Ozivy brand and denied Novo Nordisk's request to prevent the use of the name by EMS
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
